423 related articles for article (PubMed ID: 29344582)
1. Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice.
Kattula S; Byrnes JR; Martin SM; Holle LA; Cooley BC; Flick MJ; Wolberg AS
Blood Adv; 2018 Jan; 2(1):25-35. PubMed ID: 29344582
[TBL] [Abstract][Full Text] [Related]
2. Factor XIII activity mediates red blood cell retention in venous thrombi.
Aleman MM; Byrnes JR; Wang JG; Tran R; Lam WA; Di Paola J; Mackman N; Degen JL; Flick MJ; Wolberg AS
J Clin Invest; 2014 Aug; 124(8):3590-600. PubMed ID: 24983320
[TBL] [Abstract][Full Text] [Related]
3. Factor XIII cotreatment with hemostatic agents in hemophilia A increases fibrin α-chain crosslinking.
Beckman JD; Holle LA; Wolberg AS
J Thromb Haemost; 2018 Jan; 16(1):131-141. PubMed ID: 29080382
[TBL] [Abstract][Full Text] [Related]
4. The factor XIII-A Val34Leu polymorphism decreases whole blood clot mass at high fibrinogen concentrations.
Kattula S; Bagoly Z; Tóth NK; Muszbek L; Wolberg AS
J Thromb Haemost; 2020 Apr; 18(4):885-894. PubMed ID: 31989767
[TBL] [Abstract][Full Text] [Related]
5. Factor XIII deficiency does not prevent FeCl
Tang Z; Kattula S; Holle LA; Cooley BC; Lin FC; Wolberg AS
Res Pract Thromb Haemost; 2020 Jan; 4(1):111-116. PubMed ID: 31989092
[TBL] [Abstract][Full Text] [Related]
6. Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking.
Byrnes JR; Duval C; Wang Y; Hansen CE; Ahn B; Mooberry MJ; Clark MA; Johnsen JM; Lord ST; Lam WA; Meijers JC; Ni H; Ariëns RA; Wolberg AS
Blood; 2015 Oct; 126(16):1940-8. PubMed ID: 26324704
[TBL] [Abstract][Full Text] [Related]
7. Newly-Recognized Roles of Factor XIII in Thrombosis.
Byrnes JR; Wolberg AS
Semin Thromb Hemost; 2016 Jun; 42(4):445-54. PubMed ID: 27056150
[TBL] [Abstract][Full Text] [Related]
8. Factor XIII and Fibrin Clot Properties in Acute Venous Thromboembolism.
Ząbczyk M; Natorska J; Undas A
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562624
[TBL] [Abstract][Full Text] [Related]
9. FXIII polymorphisms, fibrin clot structure and thrombotic risk.
Kobbervig C; Williams E
Biophys Chem; 2004 Dec; 112(2-3):223-8. PubMed ID: 15572253
[TBL] [Abstract][Full Text] [Related]
10. Factor XIII A-Subunit V34L Variant Affects Thrombus Cross-Linking in a Murine Model of Thrombosis.
Duval C; Ali M; Chaudhry WW; Ridger VC; Ariëns RA; Philippou H
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):308-16. PubMed ID: 26743168
[TBL] [Abstract][Full Text] [Related]
11. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
Siebenlist KR; Meh DA; Mosesson MW
Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
[TBL] [Abstract][Full Text] [Related]
12. Factor XIII Prevents Pulmonary Emboli in Mice by Stabilizing Deep Vein Thrombi.
Shaya SA; Gani DM; Weitz JI; Kim PY; Gross PL
Thromb Haemost; 2019 Jun; 119(6):992-999. PubMed ID: 31005064
[TBL] [Abstract][Full Text] [Related]
13. Screening cleavage of Factor XIII V34X Activation Peptides by thrombin mutants: A strategy for controlling fibrin architecture.
Jadhav MA; Goldsberry WN; Zink SE; Lamb KN; Simmons KE; Riposo CM; Anokhin BA; Maurer MC
Biochim Biophys Acta Proteins Proteom; 2017 Oct; 1865(10):1246-1254. PubMed ID: 28687225
[TBL] [Abstract][Full Text] [Related]
14. Factor XIII topology: organization of B subunits and changes with activation studied with single-molecule atomic force microscopy.
Protopopova AD; Ramirez A; Klinov DV; Litvinov RI; Weisel JW
J Thromb Haemost; 2019 May; 17(5):737-748. PubMed ID: 30773828
[TBL] [Abstract][Full Text] [Related]
15. Whole blood clots are more resistant to lysis than plasma clots--greater efficacy of rivaroxaban.
Varin R; Mirshahi S; Mirshahi P; Klein C; Jamshedov J; Chidiac J; Perzborn E; Mirshahi M; Soria C; Soria J
Thromb Res; 2013 Mar; 131(3):e100-9. PubMed ID: 23313382
[TBL] [Abstract][Full Text] [Related]
16. Plasma fibrin clots of pulmonary embolism patients present increased amounts of factor XIII and alpha2-antiplasmin at 3 months' anticoagulation since the acute phase.
Zabczyk M; Natorska J; Bagoly Z; Sarkady F; Barath B; Katona E; Bryk A; Zettl K; Wisniewski JR; Undas A
J Physiol Pharmacol; 2020 Aug; 71(4):. PubMed ID: 33214340
[TBL] [Abstract][Full Text] [Related]
17. Red blood cells modulate structure and dynamics of venous clot formation in sickle cell disease.
Faes C; Ilich A; Sotiaux A; Sparkenbaugh EM; Henderson MW; Buczek L; Beckman JD; Ellsworth P; Noubouossie DF; Bhoopat L; Piegore M; Renoux C; Bergmeier W; Park Y; Ataga KI; Cooley B; Wolberg AS; Key NS; Pawlinski R
Blood; 2019 Jun; 133(23):2529-2541. PubMed ID: 30952675
[TBL] [Abstract][Full Text] [Related]
18. Factor XIII is a newly identified binding partner for platelet collagen receptor GPVI-dimer-An interaction that may modulate fibrin crosslinking.
Moroi M; Induruwa I; Farndale RW; Jung SM
Res Pract Thromb Haemost; 2022 Mar; 6(3):e12697. PubMed ID: 35494504
[TBL] [Abstract][Full Text] [Related]
19. Promotion of the crosslinking of fibrin and alpha 2-antiplasmin by platelets.
Hevessy Z; Haramura G; Boda Z; Udvardy M; Muszbek L
Thromb Haemost; 1996 Jan; 75(1):161-7. PubMed ID: 8713796
[TBL] [Abstract][Full Text] [Related]
20. Factor XIII, clot structure, thrombosis.
Bagoly Z; Koncz Z; Hársfalvi J; Muszbek L
Thromb Res; 2012 Mar; 129(3):382-7. PubMed ID: 22197181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
